Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Dayton & Montgomery County Public Health hosted its ninth annual “Rocking our Red Pumps” event on Friday to recognize ...